219 related articles for article (PubMed ID: 17308979)
21. Hepatitis B virus replication in well differentiated mouse hepatocyte cell lines immortalized by plasmid DNA.
Chen SH; Hu CP; Chang CM
Cancer Res; 1992 Mar; 52(5):1329-35. PubMed ID: 1737394
[TBL] [Abstract][Full Text] [Related]
22. Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs?
Yang J; Bo XC; Yao J; Yang NM; Wang SQ
J Viral Hepat; 2005 Jul; 12(4):357-63. PubMed ID: 15985005
[TBL] [Abstract][Full Text] [Related]
23. [Inhibition of hepatitis B viral gene expression and replication in vitro by targeted antisense oligonucleotides].
Zhong S; Zhang D; Wen S
Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):392-5, 444. PubMed ID: 7553155
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
25. [Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV].
Liang WF; Liu ZH; Yang J; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1374-5. PubMed ID: 17884782
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
27. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene.
Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H
Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
29. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
30. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
[TBL] [Abstract][Full Text] [Related]
31. Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2.
Huang Q; Wang L; Bai S; Lin W; Chen W; Lin J; Lin X
J Med Virol; 2009 Sep; 81(9):1539-50. PubMed ID: 19626621
[TBL] [Abstract][Full Text] [Related]
32. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
33. The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells.
Lu YW; Tan TL; Chan V; Chen WN
Biochem Biophys Res Commun; 2006 Dec; 351(1):64-70. PubMed ID: 17049490
[TBL] [Abstract][Full Text] [Related]
34. Microfluidic platform for hepatitis B viral replication study.
Sodunke TR; Bouchard MJ; Noh HM
Biomed Microdevices; 2008 Jun; 10(3):393-402. PubMed ID: 18165913
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
Han J; Pan X; Gao Y; Weil L
Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
[TBL] [Abstract][Full Text] [Related]
36. Replication of hepatitis B virus which carries foreign DNA in vitro.
Hanafusa T; Yumoto Y; Hada H; Shinji T; Koide N; Tsuji T
Biochem Biophys Res Commun; 1999 Aug; 262(2):530-3. PubMed ID: 10462508
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
38. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
39. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
Fellig Y; Almogy G; Galun E; Ketzinel-Gilad M
Biochem Biophys Res Commun; 2004 Aug; 321(2):269-74. PubMed ID: 15358171
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
Kayhan H; Karatayli E; Turkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
Arch Virol; 2007; 152(5):871-9. PubMed ID: 17245534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
